Industry breathes sigh of relief as government drops generic substitution plans for England
This article was originally published in SRA
Executive Summary
The UK coalition government has dropped plans to introduce automatic generic substitution in England after a consultation on the proposals revealed stakeholder concern that the plans could risk patient safety and scepticism at how much the scheme could actually save1,2. The R&D-based pharmaceutical industry appears to be relieved.